GlassScriptPhysician profile
John R Herald
NPI 1518378835
$1,510.41
in general payments reported to CMS, 2019-2025
11 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $125 · 2024: $305 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $245.08 | 2019 | |
| Novartis Pharmaceuticals Corporation | $201.33 | 2019-2025 | |
| Edwards Lifesciences Corporation | $175.98 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $163.60 | 2024-2025 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor |
| Ironwood Pharmaceuticals, INC | $124.99 | 2019 | |
| Allergan, INC. | $124.86 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $124.78 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.86 | 2024-2025 | Lifevest |
| Abiomed | $109.89 | 2024-2025 | Impella |
| Medtronic, INC. | $82.74 | 2024-2025 | Corevalve Evolut R, Pulseselect, Affera Mapping System |
| Biotronik INC. | $45.30 | 2025 | Orsiro Mission |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Herald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.